EHA2026レポート② Late-breaking Session

難治性原発性ITPに対するBCMA標的CAR-T療法、
4人中3人で持続的寛解と免疫再構築を確認：第Ⅰ相試験 BCMA CAR-T CELL THERAPY INDUCES COMPREHENSIVE IMMUNE RESETTING AND DURABLE REMISSION IN REFRACTORY PRIMARY IMMUNE THROMBOCYTOPENIA (#LB5003)

Jinhui Shu（Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China）